Fact Based List:
Watson Health Perspectives: 6 considerations for value-based contracting for medications
Submitted by Charlene Ice on Mon, 11/23/2020 - 16:57
- How life sciences companies and payers will set the correct unit of value.
- Clarity about who will bear the administrative burden of documenting patient outcomes.
- Outcomes might unintentionally drive price increases.
- Value-based contracts could impact off-label utilization.
- How this information could affect quality indicators in the future.
- Addressing other regulatory issues, such as Medicaid’s “best price” policy.
Notes: From a blog by Arti Bhavsar PharmD, Linda Elbers PharmD, and Katherine Haverty.
Source: Watson Health Perspectives/IBM, November 6, 2020
Source URL: https://www.ibm.com/blogs/watson-health/considerations-contr...
Printer-friendly version
Send to friend| List Ratings: |
Lists You Might Also Be Interested In
- Max Reynolds, JD: 4 Value-based Purposes for Physician Compensation Recognized by CMS
- Philip Betbeze: 6 Ways to Succeed in Value-Based Care
- Niko Lehman-White and Saeed Aminzadeh: 5 ways payers can reduce churn to increase value
- Heather R. Huhman: 5 Inexpensive Benefits Millennials Value More Than Health Insurance
- Parag Shah: 4 Ways for Revenue Cycle Management to Engage in Value-Based Transformation
Login or register to post comments
